Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.20p
   
  • Change Today:
    -0.30p
  • 52 Week High: 6.00p
  • 52 Week Low: 1.73p
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 215,093
  • Market Cap: £247.85m
  • RiskGrade: 268
  • Beta: 0.25

Latest ShareCast News

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

Allergy Therapeutics confident in funding as results remain late

By Josh White

Date: Friday 20 Jan 2023

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.

Allergy Therapeutics pauses production at Freeman facility

By Josh White

Date: Tuesday 04 Oct 2022

(Sharecast News) - Biotechnology company Allergy Therapeutics has "proactively paused" production at the Freeman facility, part of its Worthing manufacturing site, to accelerate ongoing site improvements, it announced on Tuesday.

Allegy Therapeutics trades 'robustly' in tough y... 15-Jul-2022 ShareCast
Allergy Therapeutics reports positive results fr... 25-Oct-2021 ShareCast
Allergy Therapeutics upbeat on ex-vivo study of ... 03-Aug-2021 ShareCast
Allergy Therapeutics FY profits seen 'well ahead... 24-Jun-2021 ShareCast
Allergy Therapeutics completes treatment in G309... 06-May-2021 ShareCast
Allergy Therapeutics reports record pre-R&D oper... 03-Mar-2021 ShareCast
Allergy Therapeutics trades in line, H1 revenues... 13-Jan-2021 ShareCast
Allergy Therapeutics begins peanut allergy vacci... 05-Jan-2021 ShareCast
Allergy Therapeutics screens first patients in g... 26-Oct-2020 ShareCast
Allergy Therapeutics signs new vaccine deal with... 03-Sep-2020 ShareCast
Allergy Therapeutics revenues grow despite Covid... 15-Jul-2020 ShareCast
Allergy Therapeutics pleased with invalidation o... 09-Jul-2020 ShareCast
Allergy Therapeutics on track to 'significantly'... 24-Jun-2020 ShareCast
Allergy Therapeutics to take 'stepwise approach'... 26-Nov-2019 ShareCast
Allergy Therapeutics earnings set to top expecta... 27-Jun-2019 ShareCast
Allergy Therapeutics flags positive outcomes fro... 20-May-2019 ShareCast
Allergy Therapeutics eyes 2020 start for hay fev... 25-Apr-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 5.20p
Change Today -0.30p
% Change -5.45 %
52 Week High 6.00p
52 Week Low 1.73p
Volume 215,093
Shares Issued 4,766.44m
Market Cap £247.85m
Beta 0.25
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.81% below the market average69.81% below the market average69.81% below the market average69.81% below the market average69.81% below the market average
56% below the sector average56% below the sector average56% below the sector average56% below the sector average56% below the sector average
Price Trend
51.33% above the market average51.33% above the market average51.33% above the market average51.33% above the market average51.33% above the market average
59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average
Income Not Available
Growth
55.78% below the market average55.78% below the market average55.78% below the market average55.78% below the market average55.78% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

AGY Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:35 87,480 @ 5.20p
16:35 30,000 @ 5.20p
16:35 24,359 @ 5.20p
16:35 25,641 @ 5.20p
16:35 5,323 @ 5.20p

AGY Key Personnel

CEO Manuel Llobet

Top of Page